Related Experiment Video
Updated: Jun 12, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
The Hammersmith Hospital hematopathology case of the month: myeloid sarcoma with Langerhans cell proliferation
Kikkeri N Naresh1, Simon Zokaie, Krishna Swamy Madhavan
1Departments of Histopathology, Hammersmith Hospital Campus, Imperial College Healthcare NHS Trust and Imperial College, London, UK. k.naresh@imperial.ac.uk
Abstract:
We present a patient whose initial lymph node biopsy showed extensive histiocyte and Langerhans cell infiltration, which obscured the underlying myeloid sarcoma (MS). The initial diagnosis of Langerhans cell histiocytosis (LCH) was not compatible with the disease evolution, and a subsequent biopsy performed much later showed all the characteristics of MS. Clinical distinction between LCH and MS involving the skin and management of these diseases, and the reported association of LCH/Langerhans cell proliferations with myeloid and lymphoid malignancies, are discussed.